Search - tctmd.com

Displaying 201 - 220 of 770

Sort: Relevancy | Date

Presentation TCT 2019

Keynote Lecture 1: Current Approach for Left Main Bifurcation Stenting

Presenter: Shao-Liang Chen

September 26, 2019

Presentation TCT 2019

Potential Hazards of Re-Stenting

Presenter: David Kandzari

September 26, 2019

Presentation TCT 2019

TCT 72: Validation of Complex Bifurcation Lesion Definition and Comparing Stenting Strategy in a Large Cohort of Patients with Left Main Bifurcation

Presenter: Changdong Guan

September 25, 2019

Presentation TCT 2019

TCT 19: Outcome of Coronary Ostial Stenting to Prevent Coronary Obstruction During TAVR: an International Multicenter Registry

Presenter: Antonio Mangieri

September 25, 2019

Presentation TCT 2019

TCT 17: Coronary Obstruction Risk Assessment: A Comparison of Snorkel Stenting and BASILICA

Presenter: John Lisko, MD

September 25, 2019

News Daily News

CMS Weighs Reimbursement for Out-of-Hospital Coronary Interventions

Caitlin E. Cox

September 20, 2019

News Conference News ESC 2019

AFIRE Supports Rivaroxaban Monotherapy in A-fib Patients With Stable CAD

Todd Neale

September 02, 2019

News Conference News ESC 2019

CONDI-2/ERIC-PPCI Puts the Kibosh on Ischemic Conditioning in STEMI

Yael L. Maxwell

September 01, 2019

News Conference News ESC 2019

Ticagrelor Risky in Diabetic Patients With Stable CAD: THEMIS

Michael O'Riordan

September 01, 2019

News Daily News

CTO PCI Consensus Document Aims for Quality, Consistency but Acknowledges Data Gaps

Yael L. Maxwell

August 08, 2019

News Daily News

Hybrid Revascularization for Multivessel CAD Rarely Used in the US

Todd Neale

July 04, 2019

News Conference News EuroPCR 2019

Early Days With OCT-Derived FFR Technology, but New Data Suggest Promise

Caitlin E. Cox

June 06, 2019

News Conference News SCAI 2019

FFR Changes Treatment Plan in More Than One-Third of All-Comer Patients

Yael L. Maxwell

June 04, 2019

News Conference News SCAI 2019

Cancer and CV Disease Care: What’s Known? What Lies Ahead for Cardio-Oncology?

Yael L. Maxwell

May 30, 2019

News Conference News EuroPCR 2019

Drug-Coated Balloons in STEMI ‘Safe and Feasible’ in Specific Circumstances: REVELATION

L.A. McKeown

May 22, 2019

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

News Industry News

FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy

May 13, 2019

News Daily News

Staged, Complete PCI Beats Culprit Stenting Out to 5 Years in STEMI Patients

Caitlin E. Cox

May 10, 2019

News Industry News

FDA Approves Initiation of STEMI DTU Pivotal Randomized Controlled Trial

May 02, 2019

News Features

Twitter Takes on the Times of India, but the Question Persists: Is Foregoing a Stent an Option?

Shelley Wood

April 30, 2019

Advertisement

Keynote Lecture 1: Current Approach for Left Main Bifurcation Stenting

Potential Hazards of Re-Stenting

TCT 72: Validation of Complex Bifurcation Lesion Definition and Comparing Stenting Strategy in a Large Cohort of Patients with Left Main Bifurcation

TCT 19: Outcome of Coronary Ostial Stenting to Prevent Coronary Obstruction During TAVR: an International Multicenter Registry

TCT 17: Coronary Obstruction Risk Assessment: A Comparison of Snorkel Stenting and BASILICA

CMS Weighs Reimbursement for Out-of-Hospital Coronary Interventions

AFIRE Supports Rivaroxaban Monotherapy in A-fib Patients With Stable CAD

CONDI-2/ERIC-PPCI Puts the Kibosh on Ischemic Conditioning in STEMI

Ticagrelor Risky in Diabetic Patients With Stable CAD: THEMIS

CTO PCI Consensus Document Aims for Quality, Consistency but Acknowledges Data Gaps

Hybrid Revascularization for Multivessel CAD Rarely Used in the US

Early Days With OCT-Derived FFR Technology, but New Data Suggest Promise

FFR Changes Treatment Plan in More Than One-Third of All-Comer Patients

Cancer and CV Disease Care: What’s Known? What Lies Ahead for Cardio-Oncology?

Drug-Coated Balloons in STEMI ‘Safe and Feasible’ in Specific Circumstances: REVELATION

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy

Staged, Complete PCI Beats Culprit Stenting Out to 5 Years in STEMI Patients

FDA Approves Initiation of STEMI DTU Pivotal Randomized Controlled Trial

Twitter Takes on the Times of India, but the Question Persists: Is Foregoing a Stent an Option?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content